Ligand Pharmaceuticals Incorporated is a company in the U.S. stock market and it is a holding in 90 U.S.-traded ETFs. LGND has around 2.7M shares in the U.S. ETF market. The largest ETF holder of LGND is the iShares Core S&P Mid-Cap ETF (IJH), with approximately 456.98K shares. Investors may also find of interest that the ETF with the largest allocation to LGND stock is Virtus LifeSci Biotech Products ETF (BBP), with a portfolio weight of 2.72%. On average, U.S. ETFs allocate 0.21% of LGND to their portfolios.
Additionally, LGND is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with LGND as a holding is the iShares Morningstar Small-Cap ETF (ISCB), with a return of 592.66%.